🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The importance of identifying new and putative target antigens associated with membranous nephropathy: evidence from a Sardinian cohort doi.org/10.1093/ckj/sf…

Polyoma virus 'crescents' in a case of BK nephropathy in a kidney transplant patient. SV40 demonstrates parietal epithelial cell positivity on deeper levels. BK viremia >3 million recently. #renalpath #pathtwitter #nephrology

American Society of Onconephrology Educational Series presents a seminar on “Updates on the Pathology of MGRS lesions” by Professor Samih Nasr moderated by Dr. Chintan Shah 🌟May 23, 12 PM EST 🌟Don’t miss the great opportunity !

The 7th International Renal Meeting with Mayo Clinic Nephrology in Sardinia. From the 1st congress in 2011 to our 7th International Renal Meeting (May 29–June 1, 2025), we have exchanged fellows, co-authored many research projects. Join us in Cagliari 🇮🇹 sardiniameeting.it/event/the-seve…

This Dx often not the mind of nephrologist- always surprised by Dx Fibrillary Glomerulonephritis LM: Membranoproliferative GN IF: IgG 3+, polyclonal=3+ kappa & lambda EM: fibrillary deposits DNAJB9 positive, Congo red negative 65 yr obese lady, hematuria & proteinuria. Cr 2

𝐑𝐓𝐗 treatment in 𝐦𝐞𝐦𝐛𝐫𝐚𝐧𝐨𝐮𝐬 𝐧𝐞𝐩𝐡𝐫𝐨𝐩𝐚𝐭𝐡𝐲 excellent 𝐥𝐨𝐧𝐠-𝐭𝐞𝐫𝐦 renal survival‼️ Giving New Evidence‼️ 🙏🙏🙏Mayo Clinic Nephrology maria jose vargas Sanjeev Sethi fernando fervenza Miriam Machado Ladan Zand Ilario Russo, MD Vall d'Hebron kireports.org/article/S2468-…

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy - Kidney International Nattawat Klomjit ⁦fernando fervenza⁩ ⁦Sanjeev Sethi⁩ kidney-international.org/article/S0085-…

Mayo MGRS Prediction Tool calculator mdevans.shinyapps.io/mgrs_app/

Our Mayo Clinic Nephrology ‘s Dr. Fernando C. Fervenza presented: “Lupus Nephritis: Redefining Treatment Goals” fernando fervenza Followed by thought-provoking discussions on lupus nephritis- Dr. Ayoub and Dr.Fervenza The 7th International Renal Meeting in Sardinia 🇮🇹 Andrea Angioi, MD, FASN

Chronic changes on kidney histology by a multiclass AI model Andrew Rule Priya Alexander, MD KIReports kireports.org/article/S2468-…

🌍 ERA Congress 2025 – Vienna 🧠 Focus: Membranous Nephropathy An inspiring session chaired by Ingeborg Bajema & Michael Rudnicki. Sanjeev Sethi speaking on MGN. From anti-PLA2R to the promise of epitope-specific assays, from pathology to patient: the conversation is evolving.

📣📢 “𝟏𝐫𝐬𝐭 𝐌𝐚𝐲𝐨 𝐂𝐥𝐢𝐧𝐢𝐜 - 𝐕𝐚𝐥𝐥 𝐝’𝐇𝐞𝐛𝐫𝐨𝐧 𝐍𝐄𝐏𝐇𝐑𝐎𝐋𝐎𝐆𝐘 𝐔𝐏𝐃𝐀𝐓𝐄” save the dates 5-6 Sep Barcelona 2025. Register to [email protected] organized by Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza

Do you have crescentic IgA Nephropathy? You may qualify for a Mayo Clinic clinical trial evaluating a novel treatment for crescentic IgAN. “Avacopan in Crescentic IgAN” Learn more and see if you are eligible: Link 🔗 mayo.edu/research/clini… fernando fervenza Ladan Zand

Clinical trial at our Mayo Clinic Nephrology: Evaluating daratumumab for treatment of PGNMID (Proliferative Glomerulonephritis with Monoclonal Immune Deposits). A novel approach to a rare glomerular disease. fernando fervenza Ladan Zand Learn More🔗 mayo.edu/research/clini…

In this multi-center study we describe 3 distinct phenotypes of patients with PLA2R-MN using unsupervised machine learning! ⁦Jing ^_^⁩ fernando fervenza⁩ ⁦Shane Bobart, MD, FASN⁩ ⁦Wisit Cheungpasitporn MD FACP | FASN | FAST⁩ ⁦Maria Jose Soler⁩ ⁦NDT⁩ academic.oup.com/ndt/advance-ar…

Clinical Phenotypes and Renal Outcomes in PLA2R-Associated Membranous Nephropathy: A Multi-Center Cohort Study with Unsupervised Cluster Analysis Ladan Zand Jing ^_^ fernando fervenza Shane Bobart, MD, FASN Wisit Cheungpasitporn MD FACP | FASN | FAST Maria Jose Soler NDT #AI #Nephrology academic.oup.com/ndt/advance-ar…

Clinicopathological Characteristics and Long-Term Kidney Outcomes in Biopsy-Proven Renal Sarcoidosis Jing ^_^ Wisit Cheungpasitporn MD FACP | FASN | FAST Ladan Zand fernando fervenza #MayoClinicKidney journals.lww.com/kidney360/abst…

Mayo Clinic Laboratories' new mass spectrometry assay requires just one small tissue sample to identify 13 antigens known to cause membranous nephropathy. Learn more about this one-stop test. Sanjeev Sethi bit.ly/4k1loks

#Kidney, the Cinderella Story of Transthyretin #Amyloidosis doi.org/10.1016/j.ekir… Original Article: doi.org/10.1016/j.ekir… #KIRCommentary

🩺Diagnosis and Mx of AKI on immune checkpoint inhibitors? 🔪When to biopsy? 💉 Steroid or spare? 💊Mycophenolate vs infliximab? #OncoNephrology 🦀 Sandra Herrmann MD, FASN #AKI #ImmuneRelatedAE #NephTwitter #Nephrology #MedX 📖 doi.org/10.1093/ckj/sf… 🆕